Stockscreener 앱 받기
4.74
4.18%
0.19
시간 외 거래:
4.76
0.02
+0.42%
전일 마감가:
$4.55
열려 있는:
$4.7
하루 거래량:
1.31M
Relative Volume:
1.14
시가총액:
$379.58M
수익:
$129.42M
순이익/손실:
$17.38M
주가수익비율:
23.20
EPS:
0.2043
순현금흐름:
$13.15M
1주 성능:
-1.66%
1개월 성능:
-4.05%
6개월 성능:
-51.93%
1년 성능:
+0.00%
1일 변동 폭
$4.64
$4.95
1주일 범위
$4.39
$4.95
52주 변동 폭
$4.39
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
명칭
Niagen Bioscience Inc
전화
310-388-6706
주소
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
4.74 | 364.37M | 129.42M | 17.38M | 13.15M | 0.2043 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 개시 | Canaccord Genuity | Buy |
| 2022-08-16 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-08-11 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2019-10-16 | 개시 | Oppenheimer | Outperform |
| 2019-02-14 | 개시 | B. Riley FBR | Buy |
| 2017-11-27 | 재개 | H.C. Wainwright | Buy |
| 2017-09-25 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-03 | 개시 | Rodman & Renshaw | Buy |
모두보기
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Niagen Bioscience Increases Share Repurchase Program to $20 Million - PharmiWeb.com
Niagen Bioscience Doubles Share Repurchase Authorization to $20M - TipRanks
Niagen Bioscience doubles share buyback program to $20 million - Investing.com
Niagen Bioscience raises share buyback authorization to $20M, $2.6M repurchased to date - TradingView
Will Niagen Bioscience Inc outperform its industry peers2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Niagen Bioscience to Present at the 38th Annual ROTH Conference - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements By Investing.com - Investing.com South Africa
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Nia - PharmiWeb.com
Niagen Bioscience research program reaches 300 material agreements - Investing.com
National Advertising Division Recommends Niagen Update Tru Niagen NAD+ Claims - Happi | Household And Personal Products Industry
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen - Business Wire
Decliners Report: What is the Moat Score of Niagen Bioscience Inc2026 Retail Activity & Safe Entry Momentum Tips - baoquankhu1.vn
National Advertising Division Recommends Niagen Modify or Discontinue Certain Tru Niagen NAD+ Claims; Niagen to Appeal - The Manila Times
Bank Watch: How correlated is Niagen Bioscience Inc to the S P5002026 Intraday Action & Low Drawdown Trading Strategies - baoquankhu1.vn
Analyst Calls: Can Niagen Bioscience Inc stock outperform in a bear marketRisk Management & Weekly Hot Stock Watchlists - baoquankhu1.vn
Chart Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Niagen Bioscience (NAGE) Earnings Transcript - AOL.com
Niagen Bioscience targets 10–15% revenue growth for 2026 while expanding injectable product line - MSN
Niagen Bioscience Launches Niagen Skincare Innovation Lab - Happi | Household And Personal Products Industry
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - 巴士的報
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen - itemonline.com
FinancialContentNiagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - FinancialContent
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% - Investing.com Nigeria
Risk Off: Is now the right time to enter Niagen Bioscience Inc2026 Momentum & Risk Managed Investment Signals - baoquankhu1.vn
Is Niagen Bioscience Inc. (OCD1) stock undervalued historically2026 Top Gainers & Safe Entry Trade Reports - Naître et grandir
Sentiment Review: Can Niagen Bioscience Inc be recession proofTrade Entry Report & Safe Entry Trade Reports - baoquankhu1.vn
Why Niagen Bioscience Inc. stock appeals to dividend seekersForecast Cut & Low Risk High Reward Ideas - Naître et grandir
Niagen Bioscience (NASDAQ:NAGE) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Value Recap: Will Niagen Bioscience Inc stock hit new highs in YEAR - baoquankhu1.vn
Niagen Bioscience (NAGE) Margin Rise To 13.4% Tests Bullish Narrative Targets - simplywall.st
Analysts Are Bullish on These Healthcare Stocks: Niagen Bioscience (NAGE), Daxor (DXR) - The Globe and Mail
Niagen Bioscience FY25 Net Sales Jump 30%; Sees 10-15% Growth In FY26 - Nasdaq
Canaccord Genuity Group Cuts Niagen Bioscience (NASDAQ:NAGE) Price Target to $13.00 - MarketBeat
Niagen Bioscience 2025 Financials: $129.4M Revenue, $17.4M ProfitNews and Statistics - IndexBox
Niagen Bioscience (NAGE) Valuation Check After Strong 2025 Results And Moderated 2026 Growth Outlook - simplywall.st
Niagen Bioscience Rallies 18% After Hours: Here's Why - Benzinga
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% By Investing.com - Investing.com South Africa
Niagen Bioscience Doubles Annual Profit, CEO Signals Acquisition Hunt And GLP-1-Style Expansion— Stock Jumps After-Hours (UPDATED) - Benzinga
NAGE Earnings History & Surprises | EPS & Revenue Results | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience Inc (NAGE) Q4 2025 Earnings Call Highlights: S - GuruFocus
Niagen Bioscience earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Niagen Bioscience (NAGE) Reports Strong Q4 and Ambitious 2026 Pl - GuruFocus
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income I - PharmiWeb.com
Niagen Bioscience (NAGE) Surges 39% Following Q4 Results and Pos - GuruFocus
Niagen Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
Niagen Bioscience (NAGE) Surpasses Q4 Revenue Expectations - GuruFocus
Niagen Bioscience Reports Strong 2025 Results, Strategic Shift - TipRanks
Niagen Bioscience, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-03-04 - Seeking Alpha
Niagen Bioscience soars 38% on blowout Q4 results By Investing.com - Investing.com Canada
Niagen Bioscience Q4 Earnings Assessment - Benzinga
Niagen Bioscience Inc (NAGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):